Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sahara

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Acta Neuropathologica|February 4, 1999
A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein depositsT Arai, K Ikeda, H Akiyama, et al.
FEBS Letters|February 26, 1996
Identification and characterization of presenilin I-467, I-463 and I-374N Sahara, Y Yahagi, H Takagi, et al.
Neurochemical Research|November 14, 1997
Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42)H Akiyama, H Mori, N Sahara, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Fibrinogens Kosai and Ogasa: Bbeta15Gly-->Cys (GGT-->TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregationM Hirota-Kawadobora, F Terasawa, O Yonekawa, et al.
Neurobiology of Aging|April 30, 1998
Presenilin 1 cleavage is a universal event in human organsM Okochi, N Sahara, F Kametani, et al.
Biochemical and Biophysical Research Communications|November 30, 1994
Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's diseaseA Tamaoka, T Kondo, A Odaka, et al.
The Tohoku Journal of Experimental Medicine|November 1, 1994
Racemization: its biological significance on neuropathogenesis of Alzheimer's diseaseH Mori, K Ishii, T Tomiyama, et al.
Annals of Neurology|May 1, 1997
A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 alleleK Ikeda, H Akiyama, T Arai, et al.
The Journal of Biological Chemistry|December 30, 1994
APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brainA Tamaoka, A Odaka, Y Ishibashi, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's diseaseY Harigaya, M Shoji, T Kawarabayashi, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica|February 4, 1999
A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein depositsT Arai, K Ikeda, H Akiyama, et al.
FEBS Letters|February 26, 1996
Identification and characterization of presenilin I-467, I-463 and I-374N Sahara, Y Yahagi, H Takagi, et al.
Neurochemical Research|November 14, 1997
Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42)H Akiyama, H Mori, N Sahara, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Fibrinogens Kosai and Ogasa: Bbeta15Gly-->Cys (GGT-->TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregationM Hirota-Kawadobora, F Terasawa, O Yonekawa, et al.
Neurobiology of Aging|April 30, 1998
Presenilin 1 cleavage is a universal event in human organsM Okochi, N Sahara, F Kametani, et al.
Biochemical and Biophysical Research Communications|November 30, 1994
Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's diseaseA Tamaoka, T Kondo, A Odaka, et al.
The Tohoku Journal of Experimental Medicine|November 1, 1994
Racemization: its biological significance on neuropathogenesis of Alzheimer's diseaseH Mori, K Ishii, T Tomiyama, et al.
Annals of Neurology|May 1, 1997
A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 alleleK Ikeda, H Akiyama, T Arai, et al.
The Journal of Biological Chemistry|December 30, 1994
APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brainA Tamaoka, A Odaka, Y Ishibashi, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's diseaseY Harigaya, M Shoji, T Kawarabayashi, et al.
Pageof 5